Cargando…
Guillain-Barré syndrome and COVID-19 vaccines: focus on adenoviral vectors
COVID-19 vaccination is a life-saving intervention. However, it does not come up without a risk of rare adverse events, which frequency varies between vaccines developed using different technological platforms. The increased risk of Guillain-Barré syndrome (GBS) has been reported for selected adenov...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169623/ https://www.ncbi.nlm.nih.gov/pubmed/37180147 http://dx.doi.org/10.3389/fimmu.2023.1183258 |